A randomized phase II study of combination therapy with S-1, oral leucovorin, and oxaliplatin (SOL) and mFOLFOX6 in patients with previously untreated metastatic colorectal cancer
Crossref DOI link: https://doi.org/10.1007/s00280-015-2676-0
Published Online: 2015-01-10
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yamazaki, Kentaro
Kuwano, Hiroyuki
Ojima, Hitoshi
Otsuji, Toshio
Kato, Takeshi
Shimada, Ken
Hyodo, Ichinosuke
Nishina, Tomohiro
Shirao, Kuniaki
Esaki, Taito
Ohishi, Takashi
Denda, Tadamichi
Takeuchi, Masahiro
Boku, Narikazu
Text and Data Mining valid from 2015-01-10